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Figure 1: Autonomic Cardiovascular Axis
HPI
An	81	year	old	man	with	history	of	stage	III	lung	
cancer	presented	after	a	fall	at	home	that	occurred	
while	getting	out	of	bed	in	the	middle	of	the	night
Cancer	was	treated	with	lobectomy	and	
lymphadenectomy	5	months	prior	to	his	admission,	
followed	by	3	rounds	of	chemotherapy	with	cisplatin	
and	gemcitabine
He	was	admitted	4 days	prior	for	weakness	and	back	
pain,	and	was	empirically	started	on	tamsulosin for	
urinary	retention
Objective
Patient	was	noted	to	have	remarkable	orthostatic	
hypotension	on	admission:
BP	- HR
Supine:	180/84		- 91
Standing	:	89/39		- 121
Initial	cardiovascular	workup	reassuring	with	normal	
troponin,	EKG.	Basic	labs	were	unremarkable	except	
for	chronic	anemia
Hospital	Course
Initially	managed	with	IV	fluids	which	did	not	resolve	
his	orthostatic	hypotension
Discontinued	tamsulosin and	other	medications	with	
risks	of	falls	or	hypotension,	still	with	continued	
symptoms
On	the	first	night	after	admission,	the	patient	was	
found	to	have	dramatically	high	blood	pressures	
while	supine	with	systolic	pressure	above	200	
mmHg,	indicative	of	autonomic	neuropathy
Managed	with	compression	stockings,	abdominal	
binder,	and	getting	patient	up	to	chair	and	out	of	bed	
as	frequently	as	possible	while	minimizing	time	spent	
supine
On	5th day	of	admission,	the	patient	was	able	to	
ambulate	multiple	times	throughout	the	day	without	
hypotension,	and	was	discharged	home	
Orthostatic	hypotension	recurred	on	a	subsequent	
admission	one	month	later	and	the	patient	was	
transitioned	to	hospice	care
Diagnosis	of	Autonomic	Neuropathy
• Hypovolemic	and	medication	associated	etiologies	
were	ruled	out	when	symptoms	persisted	after	initial	
management
• Autonomic	dysfunction	was	suggested	by	severe	
supine	hypertension,	inconsistent	heart	rate	response	
to	hypotension,	and	recent	new	onset	urinary	
retention
Chemotherapy-Associated	Neuropathy
• While	uncommon,	a	number	of	case	reports1,2,3,4
describe	autonomic	neuropathy	in	association	with	
cisplatin,	which	was	determined	to	be	the	most	likely	
etiology	in	this	case,	given	the	timeline	of	
presentation	
• Neurotoxicity	from	platinum	based	drugs	is	
speculated	to	result	from	progressive	DNA-adduct	
accumulation	and	inhibition	of	DNA	repair	pathways,	
with	resultant	apoptosis5
• The	drug	accumulates	in	peripheral	nerves	and	dorsal	
root	ganglia;	while	this	more	commonly	results	in	
peripheral	neuropathy,	individual	patient	factors	
including	genetic	influences	on	DNA	repair	and	drug	
transport	mechanisms	may	explain	varying	toxicity	
effects
Management	of	Refractory	Orthostatic	Hypotension
• Severe	hypertension	limited	the	use	of	pressure	
support	medications	such	as	midodrine or	
fludrocortisone	
• This	required	creative	problem	solving	including	the	
use	of	an	abdominal	binder,	compression	stockings,	
and	minimizing	time	spent	supine	to	stabilize	the	
patient	for	discharge
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Autonomic	neuropathy	is	known	to	occur	as	a	
side	effect	of	some	chemotherapy	drugs,	
including	cisplatin.	This	report	presents	a	
patient	with	new	onset	of	autonomic	instability	
and	orthostatic	hypotension	after	receiving	
multiple	rounds	of	cisplatin	and	gemcitabine	
chemotherapy.
• Autonomic	neuropathy	is	a	rare	side	effect	associated	
with	cisplatin	chemotherapy,	which	can	result	in	
orthostatic	hypotension;	other	implicated	drugs	
include	paclitaxel,	taxanes,	and	vinca alkaloids	
• Key	points	that	indicated	an	atypical	cause	of	
orthostatic	hypotension	in	this	case	were	the	lack	of	
response	to	fluid	resuscitation	and	autonomic	
instability	with	high	blood	pressures	while	the	patient	
was	supine
• When	orthostatic	hypotension	is	complicated	by	
autonomic	instability	with	severe	hypertension,	
management	may	require	creative	strategies	including	
abdominal	binders,	compression	stockings,	physical	
therapy,	and	minimizing	time	spent	supine		
Autonomic	Axis:	Arterial	baroreceptors	and	the	carotid	sinus	sense	changes	
in	pressure,	and	send	signals	to	the	hypotalamus.	Feedback	results	in	
sympathetic	activation	at	alpha	and	beta	receptors	increasing	blood	pressure	
and	heart	rate
Tools for Management of Refractory Orthostatic Hypotension
Figure 2: Neurotoxicity of Platinum Based Chemotherapy
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